FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer
Authors
Keywords
Non-small-cell lung cancer, Squamous cell carcinoma, Adenocarcinoma, Smoking, Prognosis, <em class=EmphasisTypeItalic >FGFR1</em>
Journal
VIRCHOWS ARCHIV
Volume 465, Issue 5, Pages 547-558
Publisher
Springer Nature
Online
2014-08-02
DOI
10.1007/s00428-014-1634-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGFR1 Is Essential for Prostate Cancer Progression and Metastasis
- (2013) F. Yang et al. CANCER RESEARCH
- Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer
- (2013) Eva Pros et al. INTERNATIONAL JOURNAL OF CANCER
- Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma
- (2013) Hyojin Kim et al. Korean Journal of Pathology
- Personalized therapy on the horizon for squamous cell carcinoma of the lung
- (2013) Han Sang Kim et al. LUNG CANCER
- Frequency of Fibroblast Growth Factor Receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome
- (2013) Richard J. Young et al. ORAL ONCOLOGY
- Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non-Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
- (2012) J. Zhang et al. CLINICAL CANCER RESEARCH
- Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer
- (2012) S. A. Kono et al. CURRENT CANCER DRUG TARGETS
- Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
- (2012) Hye Ryun Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
- (2012) Eleonora Brunello et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FGFR1 Amplification in Squamous Cell Carcinoma of The Lung
- (2012) Rebecca S. Heist et al. Journal of Thoracic Oncology
- Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
- (2012) J. M. Gozgit et al. MOLECULAR CANCER THERAPEUTICS
- FGFR1 expression and gene copy numbers in human lung cancer
- (2012) Lukas H. Kohler et al. VIRCHOWS ARCHIV
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
- (2011) Amit Dutt et al. PLoS One
- Epidermal Growth Factor Receptor Mutation and p53 Overexpression during the Multistage Progression of Small Adenocarcinoma of the Lung
- (2010) Seol Bong Yoo et al. Journal of Thoracic Oncology
- A Therapeutic Target for Smoking-Associated Lung Cancer
- (2010) N. C. Turner et al. Science Translational Medicine
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- Tissue Microarrays in Clinical Oncology
- (2008) David Voduc et al. SEMINARS IN RADIATION ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started